Reaction Details |
| Report a problem with these data |
Target | Prothrombin |
---|
Ligand | BDBM50129981 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_208869 (CHEMBL808335) |
---|
IC50 | <40±n/a nM |
---|
Citation | South, MS; Case, BL; Wood, RS; Jones, DE; Hayes, MJ; Girard, TJ; Lachance, RM; Nicholson, NS; Clare, M; Stevens, AM; Stegeman, RA; Stallings, WC; Kurumbail, RG; Parlow, JJ Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex. Bioorg Med Chem Lett13:2319-25 (2003) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Prothrombin |
---|
Name: | Prothrombin |
Synonyms: | Activation peptide fragment 1 | Activation peptide fragment 2 | Coagulation factor II | F2 | Prothrombin precursor | THRB_HUMAN | Thrombin heavy chain | Thrombin light chain |
Type: | Protein |
Mol. Mass.: | 70029.57 |
Organism: | Homo sapiens (Human) |
Description: | P00734 |
Residue: | 622 |
Sequence: | MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLEREC
VEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHV
NITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQE
CSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASA
QAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETG
DGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYI
DGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTEN
DLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHP
VCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDST
RIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKY
GFYTHVFRLKKWIQKVIDQFGE
|
|
|
BDBM50129981 |
---|
n/a |
---|
Name | BDBM50129981 |
Synonyms: | 2-(5-Chloro-2-oxo-3-phenethylamino-6-phenyl-2H-pyrazin-1-yl)-N-[(S)-4-guanidino-1-(thiazole-2-carbonyl)-butyl]-acetamide | CHEMBL77982 |
Type | Small organic molecule |
Emp. Form. | C29H31ClN8O3S |
Mol. Mass. | 607.126 |
SMILES | NC(=N)NCCC[C@H](NC(=O)Cn1c(c(Cl)nc(NCCc2ccccc2)c1=O)-c1ccccc1)C(=O)c1nccs1 |
Structure |
|